Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-005232-81-NL
EUCTR2007-005232-81-NL
Active, not recruiting
Not Applicable

Wet-wrap treatment in children with atopic eczema using the wet-wrap method with diluted corticosteroids versus emollients - Wet-wrap study

Havenziekenhuis/ErasmusMC0 sites50 target enrollmentJanuary 8, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsatopic dermatitisMedDRA version: 9.1Level: LLTClassification code 10003639Term: Atopic dermatitis
DrugsElocon creamvasline 20% cetomacrogolcream

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
atopic dermatitis
Sponsor
Havenziekenhuis/ErasmusMC
Enrollment
50
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 8, 2008
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Havenziekenhuis/ErasmusMC

Eligibility Criteria

Inclusion Criteria

  • •Age 6 months\- 6 years at inclusion
  • •Diagnosis of atopic eczema with an objective SCORAD \= 40
  • •Parent/legal guardian willing to comply with the protocol
  • •Written, dated consent for subject to participate
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Known pre\-existing, serious underlying disease
  • •(secondary) infected eczema:
  • •oIn case of overt impetiginisation, wet wrapping should be delayed until 48\-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results.
  • •oEczema herpeticum is an absolute contraindication for the use of wet dressings.
  • •Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38\.3ºC).
  • •Problems in the hypothalamus\-pituitary\-adrenal axis (HPA)
  • •Systemic corticosteroid therapy
  • •Severe growth retardation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Wet-wrap treatment in children with atopic eczema using the wet-wrap method with diluted corticosteroids versus emollientsatopic dermatitisatopic eczema10014982
NL-OMON31517Havenziekenhuis40
Not yet recruiting
Not Applicable
Wet-wrap treatment in children with atopic dermatitis using the wet-wrap method with diluted corticosteroids versus emollientsatopic dermatitisatopic eczemawet-wrap therapyatopisch eczeemconstitutioneel eczeememollients
NL-OMON21806Charlotte van Sassen, KinderHaven, Havenziekenhuis Rotterdam50
Completed
Not Applicable
A Randomised Placebo-Controlled Trial to compare Dilute Bleach Baths with Water treatment of Children with Eczema.EczemaBacterial Colonisation of the SkinSkin - Dermatological conditionsInfection - Studies of infection and infectious agents
ACTRN12611000260921Dr Michael Herd64
Not yet recruiting
Not Applicable
To study the local application effect of Liquid Mixture containing Manjishtha (Rubia cordifolia Linn.) Extract In the Treatment of Dry EczemaHealth Condition 1: L20-L30- Dermatitis and eczema
CTRI/2023/01/049126Mrs Hema Vishal Nalamwar
Withdrawn
Phase 3
Beyond conventional treatment of Atopic eczema in infants: Management By specific prObiOtic strains. A double blind placebo-controlled trial.allergyatopic dermatitiseczema1000170810014982
NL-OMON34286Sint Antonius Ziekenhuis120